Fair Value Measurements (Schedule Of Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Details) (USD $)
|
Sep. 30, 2012
|
Dec. 31, 2011
|
---|---|---|
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Restricted Cash equivalents | $ 217,173 | $ 1,431,765 |
Marketable Securities | 100,000 | 1,950,000 |
Total Assets: | 317,173 | 3,381,765 |
Warrant Liabilities | 1,524,270 | 868,725 |
Level 1 [Member]
|
||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Restricted Cash equivalents | 179,673 | 1,394,265 |
Marketable Securities | 100,000 | 1,950,000 |
Total Assets: | 279,673 | 3,344,265 |
Level 2 [Member]
|
||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Restricted Cash equivalents | 37,500 | 37,500 |
Total Assets: | 37,500 | 37,500 |
Level 3 [Member]
|
||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Warrant Liabilities | $ 1,524,270 | $ 868,725 |
X | ||||||||||
- Definition
Restricted Cash And Cash Equivalents Fair Value Disclosure No definition available.
|
X | ||||||||||
- Definition
Warrant Liabilities Fair Value Disclosure No definition available.
|
X | ||||||||||
- Definition
This element represents the aggregate of the assets reported on the balance sheet at period end measured at fair value by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents investment securities as of the balance sheet date which may include marketable securities, derivative financial instruments, and investments accounted for under the equity method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|